A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer.

group support integrative medicine lung cancer mind body medicine psychosocial oncology supportive care yoga

Journal

Integrative cancer therapies
ISSN: 1552-695X
Titre abrégé: Integr Cancer Ther
Pays: United States
ID NLM: 101128834

Informations de publication

Date de publication:
Historique:
entrez: 28 12 2020
pubmed: 29 12 2020
medline: 19 8 2021
Statut: ppublish

Résumé

Lung cancer is the leading cause of cancer mortality in Canada, yet patients are often under-supported. A six-week program called Inspire Now, created to address unmet supportive care needs, was evaluated in this study. Feasibility and preliminary outcomes were assessed in order to inform future changes to the program. (1) Assess the feasibility of the program and its evaluation; (2) pilot the collection of patient-reported outcomes; (3) identify outcomes that may be positively influenced; and (4) inform program modifications. Participants were recruited from the first session of Inspire Now for an observational pilot study. The primary outcome was feasibility. Secondary outcomes included within-person changes in Functional Assessment of Cancer Therapy - Lung (FACT-L) and Measure Yourself Concerns and Wellbeing (MYCaW), and program satisfaction and qualitative experiences of participants and facilitators through internally-developed questionnaires and semi-structured interviews. Analysis was primarily descriptive, within person changes in FACT-L and MYCaW were analyzed using the Wilcoxon signed-rank test and qualitative data was assessed for common themes. The program and its evaluation were feasible; 8 of 9 (89%) participants consented to the study, median attendance was 6 of 6 sessions (IQR 4.5-6), and questionnaire completion was 100% at baseline and 75% at follow-up. There were clinically meaningful improvements in MYCaW concern 1 (-1.2, 95% CI -2.0 to -0.4) and overall wellbeing (-0.9, 95% CI -2.1 to 0.4). Seven of eight FACT-L sub-sections trended toward improvement, with absolute changes ranging from -1.7 to 10.8%. Participant feedback was overwhelmingly positive; group support and social interactions were highly valued. The group intervention for people with lung cancer was feasible to both run and evaluate. Participants responded positively to the program. Findings will inform changes to future sessions and an analysis of multiple sessions is planned.

Sections du résumé

BACKGROUND
Lung cancer is the leading cause of cancer mortality in Canada, yet patients are often under-supported. A six-week program called Inspire Now, created to address unmet supportive care needs, was evaluated in this study. Feasibility and preliminary outcomes were assessed in order to inform future changes to the program.
OBJECTIVES
(1) Assess the feasibility of the program and its evaluation; (2) pilot the collection of patient-reported outcomes; (3) identify outcomes that may be positively influenced; and (4) inform program modifications.
METHODS
Participants were recruited from the first session of Inspire Now for an observational pilot study. The primary outcome was feasibility. Secondary outcomes included within-person changes in Functional Assessment of Cancer Therapy - Lung (FACT-L) and Measure Yourself Concerns and Wellbeing (MYCaW), and program satisfaction and qualitative experiences of participants and facilitators through internally-developed questionnaires and semi-structured interviews. Analysis was primarily descriptive, within person changes in FACT-L and MYCaW were analyzed using the Wilcoxon signed-rank test and qualitative data was assessed for common themes.
RESULTS
The program and its evaluation were feasible; 8 of 9 (89%) participants consented to the study, median attendance was 6 of 6 sessions (IQR 4.5-6), and questionnaire completion was 100% at baseline and 75% at follow-up. There were clinically meaningful improvements in MYCaW concern 1 (-1.2, 95% CI -2.0 to -0.4) and overall wellbeing (-0.9, 95% CI -2.1 to 0.4). Seven of eight FACT-L sub-sections trended toward improvement, with absolute changes ranging from -1.7 to 10.8%. Participant feedback was overwhelmingly positive; group support and social interactions were highly valued.
CONCLUSIONS
The group intervention for people with lung cancer was feasible to both run and evaluate. Participants responded positively to the program. Findings will inform changes to future sessions and an analysis of multiple sessions is planned.

Identifiants

pubmed: 33356632
doi: 10.1177/1534735420983472
pmc: PMC7768835
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1534735420983472

Références

Ann Oncol. 2015 Sep;26(9):1846-1858
pubmed: 25888610
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
pubmed: 19474385
J Complement Integr Med. 2013 Jun 26;10:
pubmed: 23828333
Support Care Cancer. 2007 Aug;15(8):963-71
pubmed: 17619910
BMC Public Health. 2012 Jul 17;12:526
pubmed: 22800364
Eur J Oncol Nurs. 2013 Aug;17(4):449-64
pubmed: 23246484
J Clin Epidemiol. 2002 Mar;55(3):285-95
pubmed: 11864800
Curr Oncol. 2018 Oct;25(5):338-341
pubmed: 30464683
Support Care Cancer. 2016 Jul;24(7):2999-3009
pubmed: 26872793
Integr Cancer Ther. 2015 Sep;14(5):446-51
pubmed: 25917816
J Clin Oncol. 2014 May 10;32(14):1480-501
pubmed: 24711559
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Integr Cancer Ther. 2015 Jan;14(1):26-34
pubmed: 25384697
Integr Cancer Ther. 2016 Dec;15(4):435-445
pubmed: 27060342
Cancer. 2019 Apr 15;125(8):1350-1356
pubmed: 30620401
Chest. 2013 May;143(5 Suppl):e420S-e436S
pubmed: 23649450
Curr Oncol. 2018 Apr;25(2):176-179
pubmed: 29719434
Adv Exp Med Biol. 2018;1096:19-29
pubmed: 29616481
Lung Cancer. 1995 Jun;12(3):199-220
pubmed: 7655830
Curr Oncol. 2016 Aug;23(4):258-65
pubmed: 27536176
Oncol Nurs Forum. 2014 Mar 1;41(2):162-74
pubmed: 24578076
Ann Oncol. 2013 Jun;24(6):1552-9
pubmed: 23471105
Qual Life Res. 2002 May;11(3):207-21
pubmed: 12074259
Support Care Cancer. 2009 Sep;17(9):1159-67
pubmed: 19139927

Auteurs

Ellen Conte (E)

Ottawa Integrative Cancer Centre, Ottawa, ON, Canada.
Canadian College of Naturopathic Medicine, Toronto, ON, Canada.

Mark Legacy (M)

Ottawa Integrative Cancer Centre, Ottawa, ON, Canada.

Athanasios Psihogios (A)

Ottawa Integrative Cancer Centre, Ottawa, ON, Canada.
Canadian College of Naturopathic Medicine, Toronto, ON, Canada.

Anne Pitman (A)

Ottawa Integrative Cancer Centre, Ottawa, ON, Canada.

Andrea Redway (A)

Ottawa Integrative Cancer Centre, Ottawa, ON, Canada.

Jill Hamer-Wilson (J)

Ottawa Integrative Cancer Centre, Ottawa, ON, Canada.

Dugald Seely (D)

Ottawa Integrative Cancer Centre, Ottawa, ON, Canada.
Canadian College of Naturopathic Medicine, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH